Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study

A multicenter, randomized, open-label, phase III study was conducted to compare the efficacy and safety of intravenous ferric derisomaltose (FDI) versus saccharated ferric oxide (SFO) in Japanese patients with iron deficiency anemia associated with menorrhagia. FDI can be administered as a single do...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawabata, Hiroshi, Tamura, Takeshi, Tamai, Soichiro, Fujibayashi, Akiko, Sugimura, Motoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588477/
https://www.ncbi.nlm.nih.gov/pubmed/35790696
http://dx.doi.org/10.1007/s12185-022-03401-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588477/
https://www.ncbi.nlm.nih.gov/pubmed/35790696
http://dx.doi.org/10.1007/s12185-022-03401-0

Ejemplares similares